Former Pharma Exec Settles SEC Insider Trading Claim
The former controller of a now-shuttered pharmaceutical company agreed Wednesday to pay $170,228 to settle insider trading claims from the U.S. Securities and Exchange Commission, which said he relied on material...To view the full article, register now.
Already a subscriber? Click here to view full article